Cell Therapy Testing Services
The complexities of cell therapy technologies span the development pipeline, creating challenges for manufacturing, testing requirements, regulatory approval, and commercialization. For autologous cell therapy, there is the added challenge of short timelines due to the limited “needle to needle” time specific to these therapies.
With BSL2 facilities and state-of-the-art instrumentation, and rapid testing technology, Eurofins BioPharma Product Testing network of laboratories has vast experience supporting cell therapy manufacturing from early clinical through process validation, product optimization, and marketed release.
We offer comprehensive cell and molecular biology, biochemistry, biosafety, and microbiology testing to support autologous and allogeneic cell therapies, including:
- Biologics Raw Material Testing
- Cell Banking Services
- Rapid Sterility
- Rapid Mycoplasma
- Viral Safety
- Bioassay & Potency Testing
- Stability Storage & Testing Services
- Viral vector characterization & release
- Plasmid testing
- Extractables & Leachables
We offer platform methods as well as the capability for method establishment and validation. Our teams can help bridge the gap from development to GMP testing for gene therapy clients.
Our experienced project management and technical teams serve as your single-source solution for all of your testing needs and our secure 24/7 online data portal, LabAccess.com, provides timely access to your test results.